{{Infobox drug
| Verifiedfields = changed
| verifiedrevid = 458271727
| drug_name         = 
| INN               = 
| type              = <!-- empty -->
| image             = Toujeo 300 IU-ml inj.jpg
| width             = 
| alt               = 
| caption           = 糖德仕注射劑（''Toujeo''） 

<!-- Clinical data -->
| pronounce         = 
| tradename = Lantus、Toujeo、Abasaglar
| Drugs.com = {{drugs.com|monograph|insulin_glargine}}
| MedlinePlus = a600027
| licence_CA        = <!-- Health Canada may use generic or brand name (generic name preferred) -->
| licence_EU = yes
| DailyMedID        = Insulin_glargine
| licence_US        = <!-- FDA may use generic or brand name (generic name preferred) -->
| pregnancy_AU      = B3
| pregnancy_AU_comment = <ref name="Drugs.com pregnancy">{{cite web | title=Insulin glargine Use During Pregnancy | website=Drugs.com | date=6 April 2020 | url=https://www.drugs.com/pregnancy/insulin-glargine.html | access-date=4 September 2020 | archive-date=2020-10-21 | archive-url=https://web.archive.org/web/20201021163744/https://www.drugs.com/pregnancy/insulin-glargine.html | dead-url=no }}</ref>
| pregnancy_US = N
| pregnancy_US_comment = <ref name="Drugs.com pregnancy" />
| pregnancy_category= 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = [[皮下注射|皮下注射]]
| class             = 
| ATCvet            = 
| ATC_prefix = A10
| ATC_suffix = AE04
| ATC_supplemental  =

<!-- Legal status -->
| legal_AU = S4
| legal_AU_comment = 
| legal_BR =  <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F -->
| legal_BR_comment = 
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA_comment = 
| legal_DE = <!-- Anlage I, II, III or Unscheduled -->
| legal_DE_comment = 
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment = 
| legal_UK = POM
| legal_UK_comment = <ref>{{cite web | title=Lantus 100 units/ml solution for injection in a cartridge - Summary of Product Characteristics (SmPC) | website=(emc) | url=https://www.medicines.org.uk/emc/product/2376/smpc | access-date=7 May 2020 | archive-date=2021-01-09 | archive-url=https://web.archive.org/web/20210109065757/https://www.medicines.org.uk/emc/product/2376/smpc | dead-url=no }}</ref>
| legal_US = Rx-only
| legal_US_comment = 
| legal_EU          = Rx-only
| legal_EU_comment  = 
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV -->
| legal_UN_comment = 
| legal_status      = Rx-only

<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound     = 
| metabolism = 
| metabolites       = 
| onset       = 約1小時<ref name=AHFS2018/>
| elimination_half-life = 
| duration_of_action = 24至36小時<ref name=AHFS2018/>
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 160337-95-1
| CAS_supplemental  = 
| PubChem           = 
| IUPHAR_ligand = 7572
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00047
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 2ZM8CX04RZ
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03250
| ChEBI_Ref         = 
| ChEBI             = 
| ChEMBL_Ref        = 
| ChEMBL            = 
| NIAID_ChemDB      = 
| PDB_ligand        = 
| synonyms          =

<!-- Chemical and physical data -->
| IUPAC_name = Recombinant human insulin
| C=267 | H=404 | N=72 | O=78 | S=6
| SMILES            = 
| Jmol              = 
| StdInChI          = 
| StdInChI_comment  = 
| StdInChIKey       = 
| density           = 
| density_notes     = 
| melting_point     = 
| melting_high      = 
| melting_notes     = 
| boiling_point     = 
| boiling_notes     = 
| solubility        = 
| sol_units         = 
| specific_rotation = 
}}

<!-- Definition and medical uses -->
'''甘精胰島素'''（Insulin glargine）為一種長效型[[胰岛素类似物|胰岛素]]，常用於治療[[1型糖尿病|第一型]]及[[2型糖尿病|第二型糖尿病]]<ref name=AHFS2018/>。本品可以[[皮下注射|皮下注射]]給藥，一天給予一劑<ref name="AHFS2018" />。作用則通常於給藥後一分鐘開始致效<ref name="AHFS2018" />。

<!-- Side effects and mechanism -->
常見副作用包含[[低血糖|低血糖]]、注射部位病變、搔癢，及體重增加<ref name=AHFS2018/>，其他嚴重副作用包含[[低鉀血症|低血鉀]]<ref name=AHFS2018/>等等。[[妊娠|妊娠]]期間應將本品暫時更改為[[中效胰島素|中效胰島素]]<ref name=BNF76>{{cite book |title=British national formulary: BNF 76 |date=2018 |publisher=Pharmaceutical Press |isbn=9780857113382|page=701|edition=76th}}</ref>。注射後，胰島素會以[[微晶|微晶]]形式釋出<ref name=AHFS2018/>，胰島素則會使組織吸收葡萄糖，並減少肝臟產生葡萄糖<ref name=AHFS2018/>。

<!-- Society and culture -->本品最早在美國於2000年核准用於醫藥<ref name=AHFS2018>{{cite web |title=Insulin Glargine Monograph for Professionals |url=https://www.drugs.com/monograph/insulin-glargine.html |website=Drugs.com |publisher=AHFS |accessdate=23 December 2018 |archive-date=2020-12-05 |archive-url=https://web.archive.org/web/20201205095655/https://www.drugs.com/monograph/insulin-glargine.html |dead-url=no }}</ref>。2017年，本品的年度處方量已超過2000萬劑，列名美國最常用的藥物第33位<ref>{{cite web |title=The Top 300 of 2020 |url=https://clincalc.com/DrugStats/Top300Drugs.aspx |website=ClinCalc |access-date=11 April 2020 |archive-date=2017-03-16 |archive-url=https://web.archive.org/web/20170316102646/https://clincalc.com/DrugStats/Top300Drugs.aspx |dead-url=no }}</ref><ref>{{cite web | title=Insulin Glargine - Drug Usage Statistics | website=ClinCalc | date=23 December 2019 | url=https://clincalc.com/DrugStats/Drugs/InsulinGlargine | access-date=11 April 2020 | archive-date=2020-11-29 | archive-url=https://web.archive.org/web/20201129104225/https://clincalc.com/DrugStats/Drugs/InsulinGlargine | dead-url=no }}</ref>。

== 參見 ==
* [[地特胰岛素注射液|地特胰岛素注射液]] （insulin Detemir）
* {{tsl|en|Insulin degludec||Insulin degludec}}
* [[Insulin_icodec|Insulin icodec]]

== 參考文獻 ==
{{reflist|2}}

== 外部連結 ==
* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/name/insulin%20glargine | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Insulin glargine | access-date = 2020-11-26 | archive-date = 2021-01-07 | archive-url = https://web.archive.org/web/20210107161610/https://druginfo.nlm.nih.gov/drugportal/name/insulin%20glargine | dead-url = no }}

{{Oral hypoglycemics and insulin analogs}}
{{Portal bar|醫學}}

[[Category:胰島素療法|Category:胰島素療法]]
[[Category:人类蛋白质|Category:人类蛋白质]]
[[Category:重组蛋白|Category:重组蛋白]]
[[Category:肽类激素|Category:肽类激素]]
[[Category:勃林格殷格翰|Category:勃林格殷格翰]]
[[Category:赛诺菲|Category:赛诺菲]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]